European Training Hub Expansion to Breda, Netherlands, including the grand opening of the Repligen Training & Innovation Center at the OPUS prepacked chromatography facility, broadening EU-based customer support and on-site training capabilities.

AAV Resin Innovation Launch of AVIPure HiPer AAV9 and AVIPure HiPer AAV8 affinity resins along with HiPer QA anion exchange resin in December 2025, strengthening gene therapy vector purification options and expanding the protein portfolio for next generation bioprocessing.

ML-Driven Filtration Strategic partnership with Novasign to embed machine learning and modeling workflows into Repligen filtration systems, enabling predictive performance, process optimization, and data-driven scale-up for bioprocessing facilities.

Integrated Platform Advantage A comprehensive bioprocessing portfolio spanning filtration, chromatography, process analytics, fluid management, and proteins enables a one-stop solution provider from development to manufacturing, supporting bundled solutions and faster validation for biologics and cell therapies.

Global Growth Momentum A global footprint of 22 sites and revenue in the 500 million to 1 billion range signals capacity to support cross-border deployments, regional field service, and multi-region installs across US, Europe, and APAC with potential for cross-sell opportunities.